Home › Peanut Hypersensitivity › Arkansas
Peanut Hypersensitivity clinical trials in Arkansas
4 studies for Peanut Hypersensitivity are looking for participants at sites in Arkansas.
Cities in Arkansas
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Arkansas Childrens Hosp Rsch Inst, Little Rock
RecruitingPhase 3
Ages 12 to 65 · All sexes · Updated Nov 9, 2026 · NCT07768371Study of Oral Food Challenge Biomarkers (SAFER)
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
RecruitingObservational study
12 Months – 17 Years · All sexes · Updated Oct 23, 2026 · NCT07279467Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock
RecruitingPhase 2
Ages 12 to 55 · All sexes · Updated Oct 22, 2026 · NCT07015996Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
- Arkansas Children's Hospital and Research Institute, Little Rock
RecruitingPhase 1Healthy volunteers welcome
Ages 12 to 55 · All sexes · Updated Oct 20, 2026 · NCT07287033From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.